华东医药
(000963)
| 流通市值：591.47亿 | | | 总市值：591.71亿 |
| 流通股本：17.53亿 | | | 总股本：17.54亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,734,865,777.19 | 4,978,052,188.84 | 4,375,309,533.55 | 5,160,515,681.6 |
| 应收票据及应收账款 | 11,076,591,135.34 | 8,991,801,339.36 | 11,136,300,073.66 | 9,140,791,103.75 |
| 其中：应收票据 | - | 6,213,394.05 | 5,630,773.62 | 10,757,495.21 |
| 应收账款 | 11,076,591,135.34 | 8,985,587,945.31 | 11,130,669,300.04 | 9,130,033,608.54 |
| 应收款项融资 | 332,387,014.92 | 460,578,206.16 | 642,918,508.71 | 1,248,881,871.6 |
| 预付款项 | 508,155,787.14 | 445,803,941.09 | 514,419,536.14 | 383,679,254.5 |
| 其他应收款合计 | 609,897,223.8 | 517,535,129.39 | 782,158,641.12 | 597,030,042.88 |
| 应收股利 | 223,608.84 | 223,608.84 | 223,608.84 | 1,874,730.6 |
| 存货 | 5,327,579,147.01 | 5,535,765,919.86 | 5,200,308,101.69 | 5,029,505,978.33 |
| 一年内到期的非流动资产 | 75,464,880.54 | 75,464,880.54 | - | - |
| 其他流动资产 | 139,274,907.01 | 222,343,329.23 | 69,370,755.85 | 75,925,015.51 |
| 流动资产合计 | 21,804,215,872.95 | 21,227,344,934.47 | 22,720,785,150.72 | 21,636,328,948.17 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,629,415,091.83 | 1,509,122,017.22 | 1,460,238,936.92 | 1,511,055,130.79 |
| 其他权益工具投资 | 682,132,315.02 | 681,006,253.76 | 667,868,747.53 | 665,880,883.04 |
| 投资性房地产 | 10,694,501.05 | 10,946,776.47 | 11,161,106.73 | 11,394,409.57 |
| 固定资产 | 4,389,958,201.12 | 4,470,264,264.88 | 4,223,188,950.66 | 4,282,121,438.14 |
| 在建工程 | 931,509,517.77 | 832,431,516.18 | 1,085,870,826.31 | 1,037,144,674.62 |
| 使用权资产 | 158,409,996.23 | 170,395,474.59 | 170,517,205.7 | 157,830,603 |
| 无形资产 | 3,922,211,412.97 | 3,849,691,624.59 | 3,734,873,742.82 | 3,830,341,782.22 |
| 开发支出 | 1,943,582,627.6 | 1,757,196,902.53 | 1,325,274,459.03 | 1,235,542,745.11 |
| 商誉 | 2,848,210,102.92 | 2,860,135,566.37 | 2,934,647,553.97 | 2,949,911,243.09 |
| 长期待摊费用 | 18,776,159.14 | 19,541,767.43 | 18,673,755.93 | 19,556,817.98 |
| 递延所得税资产 | 385,084,524.44 | 385,084,524.45 | 256,991,465.54 | 257,271,959.07 |
| 其他非流动资产 | 1,183,842,241.9 | 1,264,874,697.98 | 1,318,691,298.62 | 1,221,068,305.98 |
| 非流动资产合计 | 18,103,826,691.99 | 17,810,691,386.45 | 17,207,998,049.76 | 17,179,119,992.61 |
| 资产总计 | 39,908,042,564.94 | 39,038,036,320.92 | 39,928,783,200.48 | 38,815,448,940.78 |
| 流动负债: | | | | |
| 短期借款 | 1,714,508,902.52 | 1,621,903,523.77 | 1,771,270,685.28 | 1,872,106,049.23 |
| 应付票据及应付账款 | 7,609,567,039.98 | 7,969,901,859.1 | 8,770,325,148.97 | 8,073,354,049.54 |
| 其中：应付票据 | 3,017,614,936.17 | 2,910,051,094.08 | 3,675,987,092.13 | 2,501,133,508.87 |
| 应付账款 | 4,591,952,103.81 | 5,059,850,765.02 | 5,094,338,056.84 | 5,572,220,540.67 |
| 预收款项 | 502,191.65 | 797,358.84 | 1,273,682.87 | 1,480,523.27 |
| 合同负债 | 232,364,085.08 | 188,554,462.61 | 115,929,823.64 | 122,763,179.08 |
| 应付职工薪酬 | 237,138,507.68 | 411,598,841.94 | 238,395,677.39 | 290,032,508.97 |
| 应交税费 | 553,756,331.7 | 563,317,023.92 | 400,747,695.17 | 425,207,395.26 |
| 其他应付款合计 | 2,567,376,516.56 | 2,215,275,211.55 | 3,147,883,822.08 | 2,976,576,533.11 |
| 应付股利 | 101,810,219.6 | 102,560,219.6 | 125,024,219.6 | 134,138,219.6 |
| 一年内到期的非流动负债 | 82,978,800.49 | 108,871,732.55 | 107,506,993.4 | 101,669,786.32 |
| 其他流动负债 | 34,942,891.8 | 10,443,641.94 | 23,064,901.24 | 16,118,197.92 |
| 流动负债合计 | 13,033,135,267.46 | 13,090,663,656.22 | 14,576,398,430.04 | 13,879,308,222.7 |
| 非流动负债: | | | | |
| 长期借款 | 251,619,962.82 | 252,034,854.55 | 298,867,686.24 | 299,738,501.52 |
| 租赁负债 | 111,057,382.92 | 88,813,504.2 | 100,890,675.57 | 85,626,580.16 |
| 长期应付款 | - | - | 27,051,665.9 | 26,053,251.06 |
| 预计负债 | 19,922,759.61 | 20,617,015.41 | 31,923,494.11 | 32,347,741.22 |
| 递延收益 | 187,359,036.43 | 190,942,291.61 | 200,612,513.55 | 175,663,921.73 |
| 递延所得税负债 | 217,236,393.17 | 223,959,318.75 | 196,704,637.73 | 201,704,224.3 |
| 非流动负债合计 | 787,195,534.95 | 776,366,984.52 | 856,050,673.1 | 821,134,219.99 |
| 负债合计 | 13,820,330,802.41 | 13,867,030,640.74 | 15,432,449,103.14 | 14,700,442,442.69 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,753,736,848 | 1,753,736,848 | 1,754,021,048 | 1,754,077,048 |
| 资本公积 | 2,416,510,921.2 | 2,416,358,618.64 | 2,417,816,815.74 | 2,416,978,493.26 |
| 减:库存股 | - | - | 40,768,791.67 | 42,168,791.67 |
| 其他综合收益 | -74,836,933.54 | 5,770,687.07 | 32,763,430.24 | -26,842,092.12 |
| 盈余公积 | 1,616,443,486.39 | 1,616,443,486.39 | 1,395,568,477.98 | 1,395,568,477.98 |
| 未分配利润 | 20,021,219,710.05 | 19,019,030,352.89 | 18,573,486,054.02 | 18,254,304,262.55 |
| 归属于母公司股东权益合计 | 25,733,074,032.1 | 24,811,339,992.99 | 24,132,887,034.31 | 23,751,917,398 |
| 少数股东权益 | 354,637,730.43 | 359,665,687.19 | 363,447,063.03 | 363,089,100.09 |
| 股东权益合计 | 26,087,711,762.53 | 25,171,005,680.18 | 24,496,334,097.34 | 24,115,006,498.09 |
| 负债和股东权益合计 | 39,908,042,564.94 | 39,038,036,320.92 | 39,928,783,200.48 | 38,815,448,940.78 |
| 公告日期 | 2026-04-24 | 2026-04-24 | 2025-10-28 | 2025-08-20 |
| 审计意见(境内) | | 标准无保留意见 | | |